Steward Partners Investment Advisory LLC Has $594,000 Stock Holdings in CorVel Co. (NASDAQ:CRVL)

Steward Partners Investment Advisory LLC lifted its stake in CorVel Co. (NASDAQ:CRVL) by 199.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,343 shares of the business services provider’s stock after acquiring an additional 3,558 shares during the period. Steward Partners Investment Advisory LLC’s holdings in CorVel were worth $594,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of CRVL. Boston Trust Walden Corp boosted its stake in shares of CorVel by 196.8% in the 4th quarter. Boston Trust Walden Corp now owns 690,053 shares of the business services provider’s stock valued at $76,775,000 after purchasing an additional 457,538 shares in the last quarter. Bank of New York Mellon Corp boosted its position in CorVel by 184.2% during the 4th quarter. Bank of New York Mellon Corp now owns 183,447 shares of the business services provider’s stock worth $20,410,000 after acquiring an additional 118,888 shares during the last quarter. Principal Financial Group Inc. boosted its holdings in shares of CorVel by 210.2% in the 4th quarter. Principal Financial Group Inc. now owns 139,836 shares of the business services provider’s stock valued at $15,558,000 after buying an additional 94,751 shares during the last quarter. West Coast Financial LLC boosted its holdings in shares of CorVel by 201.4% in the 4th quarter. West Coast Financial LLC now owns 90,534 shares of the business services provider’s stock valued at $10,073,000 after buying an additional 60,492 shares during the last quarter. Finally, Rhumbline Advisers lifted its holdings in CorVel by 210.6% during the 4th quarter. Rhumbline Advisers now owns 84,724 shares of the business services provider’s stock valued at $9,426,000 after purchasing an additional 57,445 shares during the last quarter. Institutional investors own 51.36% of the company’s stock.

Insider Buying and Selling

In other news, Director Steven J. Hamerslag sold 10,000 shares of the business’s stock in a transaction that occurred on Thursday, February 6th. The stock was sold at an average price of $123.48, for a total transaction of $1,234,800.00. Following the completion of the sale, the director now owns 314,000 shares in the company, valued at $38,772,720. The trade was a 3.09 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Jeffrey J. Michael sold 10,477 shares of the company’s stock in a transaction on Thursday, February 20th. The stock was sold at an average price of $116.45, for a total value of $1,220,046.65. Following the sale, the director now owns 568,310 shares of the company’s stock, valued at $66,179,699.50. This trade represents a 1.81 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 32,200 shares of company stock valued at $3,824,115 over the last ninety days. 47.57% of the stock is owned by company insiders.

CorVel Stock Down 0.4 %

CorVel stock opened at $103.48 on Friday. CorVel Co. has a 12-month low of $76.20 and a 12-month high of $128.61. The business’s 50-day moving average price is $112.29 and its two-hundred day moving average price is $114.06. The stock has a market cap of $5.31 billion, a PE ratio of 60.87 and a beta of 1.06.

CorVel (NASDAQ:CRVL) last announced its quarterly earnings results on Tuesday, February 4th. The business services provider reported $0.46 EPS for the quarter. CorVel had a return on equity of 32.22% and a net margin of 10.12%.

Wall Street Analysts Forecast Growth

Separately, StockNews.com cut CorVel from a “buy” rating to a “hold” rating in a research report on Thursday.

CorVel Profile

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.